CC BY-NC-ND 4.0 · J Lab Physicians 2014; 6(01): 063-064
DOI: 10.4103/0974-2727.129098
Letters to Editor

Fatal Case of Candidemia due to Candida glabrata

Sidhartha Giri
Department of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India
,
Anupma Jyoti Kindo
Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India
,
J Kalyani
Department of Microbiology, Sri Muthukumaran Medical College, Chennai, Tamil Nadu, India
› Author Affiliations


Publication History

Article published online:
19 April 2020

© 2014.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • REFERENCES

  • 1 Rex JH, Ghannoum MA, Alexander BD, Andes D, Brown SD, Diekema DJ. In: Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved guideline M44-A2. M44-A2[24]. Pennsylvania, USA: CLSI; 2009. Ref Type: Serial (Book, Monograph).
  • 2 Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: Experience in a tertiary care center. Clin Infect Dis 2005;41:975-81.
  • 3 Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007;35:256-9.
  • 4 Sanglard D, Ischer F, Monod M, Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 1997;143:405-16.
  • 5 Borst A, Raimer MT, Warnock DW, Morrison CJ, Arthington-Skaggs BA. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob Agents Chemother 2005;49:783-7.
  • 6 Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother 2005;49:668-79.